6:59 PM
 | 
Sep 19, 2013
 |  BC Extra  |  Top Story

Acceleron soars on bumped-up IPO

Acceleron Pharma Inc. (NASDAQ:XLRN) was up $4.99 (33%) to $19.99 on Thursday after raising $83.7 million through the sale of 5.6 million shares at $15 in a bumped-up IPO at the high end of its proposed range. The $15 price valued...

Read the full 190 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >